Addex Therapeutics Ltd
ADXN
$7.29
$0.41526.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -112.42% | 503.35% | -9.44% | -8.89% | 0.43% |
| Total Depreciation and Amortization | -50.20% | 3,555.88% | -96.21% | 2,618.18% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.39% | -4,058.21% | -42.11% | 11.19% | -24.58% |
| Change in Net Operating Assets | 105.83% | -505.59% | -63.98% | 1,144.48% | 80.23% |
| Cash from Operations | 84.89% | -21.48% | -256.71% | 72.41% | 16.89% |
| Capital Expenditure | -- | -- | -- | -75.00% | 71.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.10% | -- | -- | -- | -- |
| Cash from Investing | -100.13% | -- | -- | -75.00% | 71.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 26.67% | 95.50% | 3.47% | 4.16% | -171.05% |
| Issuance of Common Stock | 450.00% | -99.83% | 521.52% | -- | -- |
| Repurchase of Common Stock | 100.00% | -371.11% | -36.36% | 83.82% | -34.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.51% | -3,260.00% | 95.85% | 75.03% | -102.87% |
| Cash from Financing | 99.06% | -133.74% | 385.58% | 69.19% | -104.29% |
| Foreign Exchange rate Adjustments | -2,261.11% | -98.39% | 148.17% | -867.99% | 118.28% |
| Miscellaneous Cash Flow Adjustments | -- | 196.68% | -- | -- | -- |
| Net Change in Cash | -121.23% | 193.33% | -155.01% | 63.30% | -256.14% |
